Fanapt Kit
NDC Package 43068-113-04
Package Information
Fanapt (iloperidone) kits is a medication used to treat certain mental/mood disorders (such as schizophrenia). This formulation utilizes a kit delivery system. Marketed by Vanda Pharmaceuticals Inc., this product is identified by NDC 43068-113 and is authorized under FDA application NDA022192.
Identification & Billing
- RxCUI: 2714234 - {4 (iloperidone 1 MG Oral Tablet) / 2 (iloperidone 2 MG Oral Tablet) / 2 (iloperidone 6 MG Oral Tablet) } Pack
- RxCUI: 2714234 - iloperidone 1 MG Oral Tablet (4) / iloperidone 2 MG Oral Tablet (2) / iloperidone 6 MG Oral Tablet (2) Titration Pack C
- RxCUI: 2714235 - {4 (iloperidone 1 MG Oral Tablet [Fanapt]) / 2 (iloperidone 2 MG Oral Tablet [Fanapt]) / 2 (iloperidone 6 MG Oral Tablet [Fanapt]) } Pack [Fanapt Titration Pack C]
- RxCUI: 2714235 - Fanapt Titration Pack C
- RxCUI: 2720356 - {6 (iloperidone 1 MG Oral Tablet) / 2 (iloperidone 2 MG Oral Tablet) / 2 (iloperidone 6 MG Oral Tablet) / 2 (iloperidone 8 MG Oral Tablet) } Pack
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 43068 - Vanda Pharmaceuticals Inc.
- 43068-113 - Fanapt
- 43068-113-04 - 1 BLISTER PACK in 1 DOSE PACK / 1 KIT in 1 BLISTER PACK
- 43068-113 - Fanapt
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43068-113-04 identifies a specific commercial package of 1 blister pack in 1 dose pack / 1 kit in 1 blister pack of Fanapt, a human prescription drug labeled by Vanda Pharmaceuticals Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This kit is formulated for oral use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Vanda Pharmaceuticals Inc. on December 01, 2015. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat certain mental/mood disorders (such as schizophrenia). Iloperidone helps you to think more clearly, feel less nervous, and take part in everyday life. It may also help to decrease hallucinations (hearing/seeing things that are not there). Iloperidone is a psychiatric medication that belongs to the class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain.
How is this Vanda Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43068011304. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.